| Vitamin B6 tethered endosomal pH responsive lipid nanoparticles for triggered intracellular release of doxorubicin S Sharma, A Verma, J Singh, BV Teja, N Mittapelly, G Pandey, S Urandur, ... ACS Applied Materials & Interfaces 8 (44), 30407-30421, 2016 | 55 | 2016 |
| Anisamide-anchored lyotropic nano-liquid crystalline particles with AIE effect: a smart optical beacon for tumor imaging and therapy S Urandur, VT Banala, RP Shukla, N Mittapelly, G Pandey, N Kalleti, ... ACS applied materials & interfaces 10 (15), 12960-12974, 2018 | 50 | 2018 |
| Hyaluronic acid anchored paclitaxel nanocrystals improves chemotherapeutic efficacy and inhibits lung metastasis in tumor-bearing rat model S Sharma, J Singh, A Verma, BV Teja, RP Shukla, SK Singh, V Sharma, ... RSC advances 6 (77), 73083-73095, 2016 | 36 | 2016 |
| Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression VT Banala, S Urandur, S Sharma, M Sharma, RP Shukla, D Marwaha, ... Biomaterials science 7 (7), 2889-2906, 2019 | 35 | 2019 |
| Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma RP Shukla, J Dewangan, S Urandur, VT Banala, M Diwedi, S Sharma, ... Biomaterials science 8 (5), 1298-1315, 2020 | 33 | 2020 |
| Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy S Urandur, VT Banala, RP Shukla, S Gautam, D Marwaha, N Rai, ... Acta Biomaterialia 113, 522-540, 2020 | 31 | 2020 |
| Synchronized ratiometric codelivery of metformin and topotecan through engineered nanocarrier facilitates in vivo synergistic precision levels at tumor site VT Banala, S Sharma, P Barnwal, S Urandur, RP Shukla, N Ahmad, ... Advanced healthcare materials 7 (19), 1800300, 2018 | 30 | 2018 |
| P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel G Pandey, N Mittapelly, GR Valicherla, RP Shukla, S Sharma, VT Banala, ... Colloids and Surfaces B: Biointerfaces 155, 276-286, 2017 | 26 | 2017 |
| Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy P Tiwari, K Yadav, RP Shukla, S Gautam, D Marwaha, M Sharma, ... Journal of Controlled Release 363, 290-348, 2023 | 24 | 2023 |
| Dacarbazine-primed carbon quantum dots coated with breast cancer cell-derived exosomes for improved breast cancer therapy P Tiwari, RP Shukla, K Yadav, N Singh, D Marwaha, S Gautam, ... Journal of Controlled Release 365, 43-59, 2024 | 18 | 2024 |
| Development of putrescine anchored nano-crystalsomes bearing doxorubicin and oleanolic acid: deciphering their role in inhibiting metastatic breast cancer RP Shukla, S Urandur, VT Banala, D Marwaha, S Gautam, N Rai, N Singh, ... Biomaterials Science 9 (5), 1779-1794, 2021 | 18 | 2021 |
| Self-assembled redox-sensitive polymeric nanostructures facilitate the intracellular delivery of paclitaxel for improved breast cancer therapy S Gautam, D Marwaha, N Singh, N Rai, M Sharma, P Tiwari, S Urandur, ... Molecular pharmaceutics 20 (4), 1914-1932, 2023 | 16 | 2023 |
| Synergistic delivery of Imatinib through multifunctional nano-crystalline capsules, in response to redox environment for improved breast cancer therapy D Marwaha, S Gautam, N Singh, N Rai, M Sharma, P Tiwari, RP Shukla, ... Colloids and Surfaces B: Biointerfaces 226, 113316, 2023 | 9 | 2023 |
| Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies P Tiwari, RP Shukla, K Yadav, D Panwar, N Agarwal, A Kumar, N Singh, ... Journal of Molecular Graphics and Modelling 128, 108702, 2024 | 8 | 2024 |
| Surface-modified lyotropic crystalline nanoconstructs bearing doxorubicin and buparvaquone target sigma receptors through pH-sensitive charge conversion to improve breast … N Singh, D Marwaha, S Gautam, N Rai, P Tiwari, M Sharma, RP Shukla, ... Biomacromolecules 24 (12), 5780-5796, 2023 | 5 | 2023 |
| Extracellular vesicles-powered immunotherapy: Unleashing the potential for safer and more effective cancer treatment P Tiwari, K Yadav, RP Shukla, AK Bakshi, D Panwar, S Das, PR Mishra Archives of Biochemistry and Biophysics 756, 110022, 2024 | 3 | 2024 |
| Regression of Smoldering Myeloma with treatment of Gaucher disease K Barley, A Parekh, SP Salam, PD Ravi Prakash Shukla, D Vatti, D Verina, ... Blood Advances, 2024 | 2 | 2024 |
| Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model RP Shukla, P Tiwari, A Sardar, S Urandur, S Gautam, D Marwaha, ... Journal of Controlled Release 372, 331-346, 2024 | | 2024 |
| Celastrol-loaded polymeric mixed micelles shows improved antitumor efficacy in 4 T1 bearing xenograft mouse model through spatial targeting S Gautam, N Singh, D Marwaha, N Rai, M Sharma, P Tiwari, S Singh, ... International Journal of Pharmaceutics 659, 124234, 2024 | | 2024 |
| Gaucher disease treatment reduces the progression of smoldering myeloma RP Shukla, A Parekh, VV Leshchenko, K Barley, D Vatti, D Verina, ... Cancer Research 84 (6_Supplement), 4807-4807, 2024 | | 2024 |
Prabhat Ranjan Mishra PhD, FNAScChief Scientist & Head, CSIR-Central Drug Research Institute, Lucknow在 cdri.res.in 的电子邮件经过验证
